Structures of γ-Aminobutyric Acid (GABA) Aminotransferase, a Pyridoxal 5′-Phosphate, and [2Fe-2S] Cluster-containing Enzyme, Complexed with γ-Ethynyl-GABA and with the Antiepilepsy Drug Vigabatrin*
暂无分享,去创建一个
Paola Storici | Francesco Bossa | Andrea Mozzarelli | Stefano Bruno | A. Mozzarelli | F. Bossa | S. Bruno | P. Storici | D. De Biase | R. Silverman | Tilman Schirmer | Tilman Schirmer | Richard B Silverman | Daniela De Biase | Caroline Peneff | C. Peneff
[1] R. Silverman,et al. Mechanism of inactivation of .gamma.-aminobutyric acid aminotransferase by 4-amino-5-hexynoic acid (.gamma.-ethynyl GABA) , 1991 .
[2] F. Fonnum,et al. Effect of the convulsive agent 3-mercaptopropionic acid on the levels of GABA, other amino acids and glutamate decarboxylase in different regions of the rat brain. , 1974, Biochemical pharmacology.
[3] W. Löscher. gamma-Acetylenic GABA antagonizes the decrease in synaptosomal GABA concentrations but not the seizures induced by 3-mercaptopropionic acid in rats. , 1986, Biochemical pharmacology.
[4] R. Rando,et al. The in vivo inhibition of GABA-transaminase by gabaculine. , 1977, Biochemical and biophysical research communications.
[5] B. Metcalf. Inhibitors of GABA metabolism. , 1979, Biochemical Pharmacology.
[6] R. Bakay,et al. Neurotransmitter, receptor and biochemical changes in monkey cortical epileptic foci , 1981, Brain Research.
[7] J. Churchich,et al. 4-Aminobutyrate aminotransferase. The presence of nonequivalent binding sites. , 1981, The Journal of biological chemistry.
[8] K. Gale. GABA in Epilepsy: The Pharmacologic Basis , 1989, Epilepsia.
[9] C. Mcphalen,et al. X-ray structure refinement and comparison of three forms of mitochondrial aspartate aminotransferase. , 1993, Journal of molecular biology.
[10] G. Johnston,et al. Piperazic acid and related compounds as inhibitors of GABA uptake in rat brain slices , 1977, The Journal of pharmacy and pharmacology.
[11] P. Frey,et al. Identification of lysine 346 as a functionally important residue for pyridoxal 5'-phosphate binding and catalysis in lysine 2, 3-aminomutase from Bacillus subtilis. , 2001, Biochemistry.
[12] F. Bossa,et al. Chemistry of the inactivation of 4-aminobutyrate aminotransferase by the antiepileptic drug vigabatrin. , 1991, The Journal of biological chemistry.
[13] D. R. Curtis,et al. A new class of GABA agonist , 1977, Nature.
[14] O. Kwon,et al. Brain 4-aminobutyrate aminotransferase. Isolation and sequence of a cDNA encoding the enzyme. , 1992, The Journal of biological chemistry.
[15] A. Jayakumar,et al. A role of nitric oxide as an inhibitor of γ-aminobutyric acid transaminase in rat brain , 2000, Brain Research Bulletin.
[16] R. Silverman,et al. Mechanisms of inactivation of γ-aminobutyric acid aminotransferase by the antiepilepsy drug γ-vinyl GABA (vigabatrin) , 1991 .
[17] D. R. Curtis,et al. 4-aminotetrolic acid: new conformational-restricted analogue of -aminobutyric acid. , 1971, Nature: New biology.
[18] G. Hammes,et al. Kinetic studies of tryptophan synthetase. Interaction of substrates with the B subunit. , 1970, Biochemistry.
[19] D. Dean,et al. nifU gene product from Azotobacter vinelandii is a homodimer that contains two identical [2Fe-2S] clusters. , 1994, Biochemistry.
[20] J. Kelly,et al. The characterisation of [3H]GABA uptake into the satellite glial cells of rat sensory ganglia , 1974 .
[21] E. Roberts,et al. The gamma-aminobutyric acid-alpha-ketoglutaric acid transaminase of beef brain. , 1958, The Journal of biological chemistry.
[22] Sun Choi,et al. Design of a conformationally restricted analogue of the antiepilepsy drug Vigabatrin that directs its mechanism of inactivation of gamma-aminobutyric acid aminotransferase. , 2002, Journal of the American Chemical Society.
[23] A. Sjoerdsma,et al. THE EFFECT OF 4‐AMINO HEX‐5‐YNOIC ACID (γ‐ACETYLENIC GABA, γ‐ETHYNYL GABA) A CATALYTIC INHIBITOR OF GABA TRANSAMINASE, ON BRAIN GABA METABOLISM IN VIVO , 1977 .
[24] A. Teelken,et al. Glutamine, glutamate and gaba in the central nervous system Edited by: L. Hertz, E. Kvamme, E.G. McGeer and A. Schousboe. Alan R. Liss, Inc. New York, 1984. Series: Neurology and Neurobiology. pp. 720, Figs and Tables, £ 66.00. ISBN 0-8451-2706-3 , 1986, Clinical Neurology and Neurosurgery.
[25] G N Murshudov,et al. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. , 2001, Acta crystallographica. Section D, Biological crystallography.
[26] L. Fowler,et al. Enzyme-induced inactivation of transminases by acetylenic and vinyl analogues of 4-aminobutyrate. , 1979, The Biochemical journal.
[27] I. Schlichting,et al. Crystal structure of wild-type tryptophan synthase complexed with the natural substrate indole-3-glycerol phosphate. , 1999, Biochemistry.
[28] R. Silverman. Mechanism-based enzyme inactivators. , 1995, Methods in enzymology.
[29] J. Simpson,et al. Phosphate‐Activated Glutaminase in Relation to Huntington's Disease and Agonal State , 1983, Journal of neurochemistry.
[30] R. Kälviäinen,et al. Visual Field Defects with Vigabatrin , 2001, CNS drugs.
[31] B. Shen,et al. Crystal structure of human recombinant ornithine aminotransferase. , 1998, Journal of molecular biology.
[32] F. Bossa,et al. Protein structure of pig liver 4‐aminobutyrate aminotransferase and comparison with a cDNA‐deduced sequence , 1992 .
[33] B. Metcalf,et al. Catalytic inhibition of γ-aminobutyric acid-α-ketoglutarate transaminase of bacterial origin by 4-aminohex-5-ynoic acid, a substrate analog , 1975 .
[34] B. Metcalf,et al. Biochemical consequences of reactions catalyzed by GAD and GABA-T , 1980, Brain Research Bulletin.
[35] M A Rogawski,et al. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. , 1990, Pharmacological reviews.
[36] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[37] C. Tanaka,et al. GABAA receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson's disease. , 1988, Japanese journal of pharmacology.
[38] A. Mozzarelli,et al. Crystals of Tryptophan Indole-Lyase and Tyrosine Phenol-Lyase Form Stable Quinonoid Complexes* , 2002, The Journal of Biological Chemistry.
[39] S. Cowan,et al. Dialkylglycine decarboxylase structure: bifunctional active site and alkali metal sites. , 1994, Science.
[40] Arthur James Cooper. [16] Glutamate-γ-aminobutyrate transaminase , 1985 .
[41] T. Aoyagi,et al. Increased gamma-aminobutyrate aminotransferase activity in brain of patients with Alzheimer's disease. , 1990, Chemical and pharmaceutical bulletin.
[42] H. Beinert,et al. Iron-sulfur clusters: nature's modular, multipurpose structures. , 1997, Science.
[43] P. Krogsgaard‐Larsen,et al. The structure of muscimol, a GABA analogue of restricted conformation. , 1972, Acta chemica Scandinavica.
[44] L. Fowler,et al. Kinetic and spectral properties of rabbit brain 4-aminobutyrate aminotransferase. , 1976, The Biochemical journal.
[45] L. Gunne,et al. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis , 1984, Nature.
[46] A. Mozzarelli,et al. Protein function in the crystal. , 1996, Annual review of biophysics and biomolecular structure.
[47] D. R. Curtis,et al. CIS‐ AND TRANS‐4‐AMINOCROTONIC ACID AS GABA ANALOGUES OF RESTRICTED CONFORMATION , 1975, Journal of neurochemistry.
[48] L. Fowler,et al. Active-site-directed irreversible inhibition of rat brain 4-aminobutyrate aminotransferase by ethanolamine O-sulphate in vitro and in vivo. , 1972, The Biochemical journal.
[49] N. Volkow,et al. A novel strategy for the treatment of cocaine addiction , 1998, Synapse.
[50] P Christen,et al. The molecular evolution of pyridoxal-5'-phosphate-dependent enzymes. , 2000, Advances in enzymology and related areas of molecular biology.
[51] P. Kiley,et al. Fe-S proteins in sensing and regulatory functions. , 1999, Current opinion in chemical biology.
[52] R. Silverman,et al. Design of potential anticonvulsant agents: mechanistic classification of GABA aminotransferase inactivators. , 1989, Journal of medicinal chemistry.
[53] M. Fontecave,et al. Biotin synthase is a pyridoxal phosphate-dependent cysteine desulfurase. , 2002, Biochemistry.
[54] B. Metcalf,et al. 4-amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. , 1977, European journal of biochemistry.
[55] W. Löscher. Comparative assay of anticonvulsant and toxic potencies of sixteen GABAmimetic drugs , 1982, Neuropharmacology.
[56] A. Mozzarelli,et al. Microspectrophotometric studies on single crystals of the tryptophan synthase alpha 2 beta 2 complex demonstrate formation of enzyme-substrate intermediates. , 1989, The Journal of biological chemistry.
[57] G. Capitani,et al. Crystal Structure of GABA-Aminotransferase, a Target for Antiepileptic Drug Therapy† , 1999 .
[58] J. Hofrichter,et al. Linear dichroism of biological chromophores. , 1976, Annual review of biophysics and bioengineering.
[59] L. Stookey. Ferrozine---a new spectrophotometric reagent for iron , 1970 .
[60] M. Privitera,et al. Vigabatrin: A Novel Therapy for Seizure Disorders , 1999, The Annals of pharmacotherapy.